X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (206) 206
Patent (23) 23
Publication (8) 8
Book / eBook (6) 6
Conference Proceeding (5) 5
Book Chapter (3) 3
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (58) 58
environmental sciences (35) 35
bacteria (31) 31
soil microbiology (31) 31
humans (30) 30
chemistry (26) 26
microbiology (26) 26
analysis (25) 25
metallurgy (24) 24
oncology (24) 24
soil (24) 24
biodegradation (22) 22
compositions based thereon (19) 19
degradation (19) 19
organic macromolecular compounds (19) 19
their preparation or chemical working-up (19) 19
bioremediation (18) 18
biodegradation, environmental (17) 17
fatty acids (17) 17
mutation (16) 16
lung neoplasms - drug therapy (15) 15
biomass (14) 14
pesticides (14) 14
female (13) 13
fungi (13) 13
lung neoplasms - genetics (13) 13
microorganisms (13) 13
soils (13) 13
acquired-resistance (12) 12
article (12) 12
diversity (12) 12
gefitinib (12) 12
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (12) 12
resistance (12) 12
male (11) 11
rhizosphere (11) 11
biotechnology & applied microbiology (10) 10
protein kinase inhibitors - pharmacology (10) 10
biological diversity (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
ecology (9) 9
erbb receptors - genetics (9) 9
functional diversity (9) 9
genes (9) 9
heavy metals (9) 9
lung neoplasms - pathology (9) 9
toxicology (9) 9
bacteria - metabolism (8) 8
bacterial communities (8) 8
biodiversity (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
erlotinib (8) 8
insecticides (8) 8
lung cancer (8) 8
microbial activity (8) 8
middle aged (8) 8
plant-growth (8) 8
plfa (8) 8
protein kinase inhibitors - therapeutic use (8) 8
receptor, epidermal growth factor - genetics (8) 8
soil pollutants - metabolism (8) 8
aged (7) 7
compositions of macromolecular compounds (7) 7
dgge (7) 7
drug resistance in microorganisms (7) 7
drug resistance, neoplasm - genetics (7) 7
environment (7) 7
environment, general (7) 7
gene (7) 7
hydrocarbons (7) 7
mechanisms (7) 7
microbial community (7) 7
original research (7) 7
phytoremediation (7) 7
pseudomonas (7) 7
soil contamination (7) 7
adult (6) 6
aged, 80 and over (6) 6
bacteria - isolation & purification (6) 6
bioaugmentation (6) 6
cell biology (6) 6
cell line, tumor (6) 6
community structure (6) 6
egfr (6) 6
enzyme activities (6) 6
life sciences (6) 6
mineralization (6) 6
performing operations (6) 6
poland (6) 6
research (6) 6
soil microorganisms (6) 6
transporting (6) 6
use of inorganic or non-macromolecular organic substances ascompounding ingredients (6) 6
acc deaminase (5) 5
afatinib (5) 5
antineoplastic agents - pharmacology (5) 5
antineoplastic agents - therapeutic use (5) 5
bacteria - growth & development (5) 5
bacterial community (5) 5
bakterien (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 18, pp. 1700 - 1709
Patients with non–small-cell lung cancer and mutated epidermal growth factor receptors who develop resistance to EGFR inhibitors through a particular mutation... 
TYROSINE KINASE INHIBITORS | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | GEFITINIB | ADENOCARCINOMA | ACQUIRED-RESISTANCE | MUTATIONS | AFATINIB | ERLOTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Acrylamides - pharmacokinetics | Dose-Response Relationship, Drug | Hyperglycemia - chemically induced | Antineoplastic Agents - adverse effects | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidines - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Acrylamides - administration & dosage | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Acrylamides - adverse effects | Clinical trials | Care and treatment | Usage | Diagnosis | Lung cancer, Non-small cell | Hyperglycemia | Chemotherapy | Epidermal growth factor | Inhibitor drugs | Epidermal growth factor receptors | Lung cancer | Genes | Non-small cell lung carcinoma | Antitumor activity | Pharmacokinetics | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Nature Communications, ISSN 2041-1723, 06/2016, Volume 7, Issue 1, p. 11815
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2016, Volume 22, Issue 3, pp. 262 - 269
Journal Article